Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor wi... Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. Mehr anzeigen
Carlsbad, CA, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
Carlsbad, CA, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.4114 | -18.7596899225 | 2.193 | 2.35 | 1.61 | 773600 | 1.80605939 | CS |
| 4 | -0.6784 | -27.5772357724 | 2.46 | 3.3 | 1.38 | 3837198 | 2.31397452 | CS |
| 12 | -1.6184 | -47.6 | 3.4 | 4.318 | 1.38 | 1315325 | 2.3506735 | CS |
| 26 | -2.8684 | -61.6860215054 | 4.65 | 5.15 | 1.38 | 638971 | 2.43411442 | CS |
| 52 | -7.3699 | -80.5321531989 | 9.1515 | 22.35 | 1.38 | 1252470 | 8.95113762 | CS |
| 156 | -1385.7184 | -99.8715963964 | 1387.5 | 1402.425 | 1.38 | 1995831 | 126.71125705 | CS |
| 260 | -6748.2184 | -99.9736059259 | 6750 | 8182.5 | 1.38 | 1767711 | 328.68535296 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
